Search alternatives:
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
w decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
Showing 201 - 220 results of 100,594 for search '(( 5 ((nm decrease) OR (a decrease)) ) OR ( 5 ((w decrease) OR (mean decrease)) ))', query time: 1.61s Refine Results
  1. 201
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 202
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 203
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 204
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 205
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 206
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 207
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 208
    Su(H) and RBPJ AOS variants decrease DNA binding.

    Su(H) and RBPJ AOS variants decrease DNA binding. by Ellen K. Gagliani (11478756)

    Published 2022
    Save to List
    Saved in:
  9. 209
    Six weeks of voluntary wheel running decreases 5-HT<sub>2C</sub> mRNA expression in the medial dorsal striatum.

    Six weeks of voluntary wheel running decreases 5-HT<sub>2C</sub> mRNA expression in the medial dorsal striatum. by Benjamin N. Greenwood (295216)

    Published 2013
    Save to List
    Saved in:
  10. 210
    Vasopressin decreases EPSPs in CA2 after LTP induction.

    Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

    Published 2013
    “…Vasopressin (AVP 10 nM; 1 min) applied during LTP transiently decreased the EPSP amplitude. …”
    Save to List
    Saved in:
  11. 211
    Berberine decreases IBMX- and FSK-induced CRE luciferase activity.

    Berberine decreases IBMX- and FSK-induced CRE luciferase activity. by Juan Zhang (48597)

    Published 2015
    Save to List
    Saved in:
  12. 212
    c-Abl inhibition decreases ABCB1 expression and activity.

    c-Abl inhibition decreases ABCB1 expression and activity. by Jonathan T. Sims (278652)

    Published 2013
    Save to List
    Saved in:
  13. 213
    Hypoxia dramatically decreased cGMP in cultured porcine retina.

    Hypoxia dramatically decreased cGMP in cultured porcine retina. by Lorena Olivares-González (3352898)

    Published 2016
    Save to List
    Saved in:
  14. 214
    CK2α decreases CLK transcription factor activity.

    CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

    Published 2013
    Save to List
    Saved in:
  15. 215
    CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells.

    CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells. by Seung-Cheol Choi (686982)

    Published 2015
    Save to List
    Saved in:
  16. 216
    Overexpression of Lethe in RAW macrophage cells decreases ROS production.

    Overexpression of Lethe in RAW macrophage cells decreases ROS production. by Carlos Zgheib (311460)

    Published 2017
    Save to List
    Saved in:
  17. 217
    HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage.

    HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

    Published 2013
    Save to List
    Saved in:
  18. 218
    CMV infection decreases TER of polarized HCoEpiC.

    CMV infection decreases TER of polarized HCoEpiC. by Ekaterina Maidji (3797899)

    Published 2017
    Save to List
    Saved in:
  19. 219
    Processive receptor methylation compromises adaptation and decreases signaling noise.

    Processive receptor methylation compromises adaptation and decreases signaling noise. by William Pontius (460803)

    Published 2013
    “…(C) Increasing processivity also decreases the magnitude of fluctuations in <i>a</i>(<i>t</i>) in the adapted state around the mean value <i>a</i><sub>0</sub>. …”
    Save to List
    Saved in:
  20. 220
    GSK-3β inhibition or silencing decreases reporter activity.

    GSK-3β inhibition or silencing decreases reporter activity. by Rong Guo (50063)

    Published 2013
    Save to List
    Saved in:

Search Tools: